Data as of Apr 17
| +1.56 / +3.49%|
The 7 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 80.00, with a high estimate of 97.00 and a low estimate of 65.00. The median estimate represents a +72.86% increase from the last price of 46.28.
The current consensus among 7 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.